Financial Health Assessment: FPINTER LIMITED

1. Financial Health Score: A

FPINTER Limited exhibits excellent financial health. The company maintains a robust asset base of approximately £4.7 million with negligible liabilities, substantial cash reserves, and a steadily growing net worth over the past decade. This is a financially vigorous entity with no symptoms of distress.

2. Key Vital Signs

Net Assets (The "Body Mass" of the Business)

Interpretation: Net assets have grown by approximately £1.83 million (63%) over the eight-year period reviewed. This is the equivalent of steady, healthy weight gain in a developing patient — the business is accumulating value consistently. The minor dips in 2022 and 2023 likely reflect investment portfolio valuation fluctuations rather than operational deterioration, given the company's minimal liability structure.

Cash at Bank (The "Circulation System")

Interpretation: Cash levels peaked in 2020 at £3.5 million and have since moderated to approximately £1.87 million. This decline is not alarming — it coincides with additions to the investment portfolio (£573,431 in the current year alone), suggesting the company is actively redeploying cash into longer-term investments rather than spending it on operational losses. The current cash position represents approximately 40% of net assets, providing excellent liquidity.

Liabilities (The "Cholesterol" of the Business)

Interpretation: Total liabilities are extraordinarily low relative to the asset base — approximately 1.9% of net assets in the current year. The current liabilities of £88,400 consist of £59,066 in taxation/social security and £29,334 in other creditors. There is also a deferred tax provision of £57,669. This is the financial equivalent of excellent cholesterol levels — the company carries virtually no debt burden.

Fixed Asset Investments (The "Core Strength")

Interpretation: The investment portfolio represents the largest component of the company's assets at £2.8 million (59% of net assets). During the current year, the company added £573,431 in new investments, realised £42,952 in valuation gains, and disposed of £518,025. The historic cost of investments stands at £2,567,818, meaning the portfolio carries approximately £235,478 in unrealised gains. This active portfolio management indicates prudent stewardship of capital.

Working Capital (The "Immune System")

• Current Assets: £2,066,059
• Current Liabilities: £88,400
• Net Current Assets: £1,977,659

Interpretation: The working capital ratio is approximately 23:1 — an extraordinarily strong position. The company could meet its short-term obligations more than twenty times over. This provides an exceptional buffer against any unforeseen financial shocks.

3. Diagnosis

Overall Financial Condition: Excellent

FPINTER Limited presents as a financially robust entity in excellent condition. The company operates as what appears to be a private investment and artistic creation vehicle, classified under SIC code 90030 (Artistic creation). With only 3 employees and a share capital of just £2, the company's substantial net asset position of £4.72 million has been built through accumulated investment gains and retained profits over its 62-year history since incorporation in 1963.

Key Diagnostic Findings:

1. No symptoms of financial distress: The company shows no warning signs — no overdraft reliance, no significant creditor pressure, no erosion of capital base, and no liquidity concerns.

2. Healthy investment activity: The portfolio is actively managed with both acquisitions and disposals, indicating engaged stewardship rather than passive holding.

3. Minimal operational risk: With only 3 employees and negligible trade creditors, the operational footprint is tiny relative to the asset base. The trade debtor figure of £146,235 (up from £30,281) suggests some revenue-generating activity, though the P&L account has not been filed (as is permitted for small companies).

4. Deferred tax provision is appropriate: The £57,669 deferred tax liability reflects unrealised gains in the investment portfolio — a normal and healthy feature of an investment-holding entity.

5. Steady capital appreciation: The trajectory from £2.89 million to £4.72 million in net assets over eight years represents a compound annual growth rate of approximately 6.3%, which is reasonable and sustainable.

4. Recommendations

While the company is in excellent financial health, the following wellness recommendations are offered:

Portfolio Diversification Review

With approximately 59% of net assets concentrated in fixed asset investments, a periodic review of investment diversification would be prudent. The accounts indicate the investments include equity instruments not publicly traded — ensuring these valuations are regularly assessed for impairment is important for ongoing financial accuracy.

Cash Utilisation Strategy

Cash holdings of £1.87 million represent approximately 40% of net assets. While this provides exceptional security, it may represent an opportunity cost. The company may wish to consider whether a portion of this cash could be more productively deployed, whether through additional investments, income-generating assets, or distributions to shareholders, depending on the strategic objectives of the person with significant control.

Succession and Continuity Planning

The company has been operating for over 60 years with a small group of officers. Given the substantial asset base, ensuring robust succession planning and continuity of management would protect the long-term value accumulated within the entity.

Filing Compliance Maintenance

The company's filing record is current and in good order. Maintaining this discipline is essential — late filing penalties, while modest, are unnecessary expenses that would blemish an otherwise immaculate financial record.

Regular Valuation Reviews

The investment portfolio carries valuations that fluctuate year to year. Ensuring independent or well-documented valuation methodologies are applied consistently will maintain the integrity of the financial statements and support informed decision-making by the directors.